Development of a resonant-type microwave reactor and its application to the synthesis of positron emission tomography radiopharmaceuticals. by Kimura, Hiroyuki et al.
Title
Development of a resonant-type microwave reactor and its
application to the synthesis of positron emission tomography
radiopharmaceuticals.
Author(s)Kimura, Hiroyuki; Yagi, Yusuke; Ohneda, Noriyuki; Odajima,Hiro; Ono, Masahiro; Saji, Hideo




This is the peer reviewed version of the following article:
Kimura H., Yagi Y., Ohneda N., Odajima H., Ono M., and Saji
H. (2014), Development of a resonant-type microwave reactor
and its application to the synthesis of positron emission
tomography radiopharmaceuticals, J. Label Compd.
Radiopharm, 57, pages 680‒686, which has been published in







Development of a resonant-type microwave reactor and its application 
to the synthesis of PET radiopharmaceuticals 
 
Hiroyuki Kimura1,2,*#, Yusuke Yagi1#, Noriyuki Ohneda3, Hiro Odajima3,  
Masahiro Ono1, and Hideo Saji1,* 
 
1Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical 
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, 
Japan 
2Radioisotope Research Center of Kyoto University, Yoshida Konoe-cho, Sakyo-ku, 
Kyoto 606-8501, Japan 





















Microwave technology has been successfully applied to enhance the 
effectiveness of radiolabeling reactions. The use of a microwave as a source of heat 
energy can allow chemical reactions to proceed over much shorter reaction times and in 
higher yields than they would do under conventional thermal conditions. A microwave 
reactor developed by Resonance Instrument Inc. (Model 520/521) and CEM 
(PETWave) has been used exclusively for the synthesis of radiolabelled agents for 
positron emission tomography (PET) by numerous groups throughout the world. In this 
study, we have developed a novel resonant-type microwave reactor powered by a 
solid-state device, and confirmed that this system can focus microwave power on a 
small amount of reaction solution. Furthermore, we have demonstrated the rapid and 
facile radiosynthesis of 16α-[18F]fluoroestradiol ([18F]FES), 
4-[18F]fluoro-N-[2-(1-methoxyphenyl)-1-piperazinyl]ethyl-N-2-pyridinylbenzamide 
([18F]MPPF) and N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) using our newly 
developed microwave reactor. 
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Since Gebye and Giguere reported microwave synthesis in a sealed tube with a 
domestic microwave oven in 1986, there has been rapid increase in research efforts 
directed towards the study of organic reactions in a microwave [1,2]. 
Based on the significance of this early work, numerous microwave reactors 
have been developed and optimized for synthetic applications, where it is possible to 
control the temperature and pressure of the reaction mixture inside the reactor. Many 
researchers have reported that the use of a microwave as a source of heat energy can 
enable reactions to proceed over much shorter reactions times and in higher yields than 
they would do under conventional thermal conditions [3 - 8]. Compounds labeled with 18F 
are used as positron emission tomography (PET) tracers. The introduction of 18F atoms 
into an organic compound (i.e., 18F-fluorination reactions), however, invariably requires 
high temperatures and long reaction times because fluoride anions are only weakly 
nucleophilic. Furthermore, the use of long reaction times for the introduction of 18F 
atoms can be problematic because the half-life of 18F (109.7 min) is very short. A 
microwave-based 18F labeling method was recently reported, and has drawn 
considerable attention from researchers working in a variety of different fields because 
this new microwave-assisted method improved yields, reduced the generation of side 
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products and shortened reaction times compared with conventional heating methods 
such as oil baths and hotplates [9 - 13]. A microwave reactor developed by Resonance 
Instrument Inc. (Model 520/521) and CEM (PETWave) has been used exclusively for 
the synthesis of radiolabelled agents for PET by numerous groups throughout the world. 
Commercial microwave reactors use a magnetron as an oscillator, which can 
struggle to irradiate small areas of a reaction mixture (such as those found in PET 
radiochemistry) with appropriate levels of power, and it can therefore be difficult for 
these systems to achieve sufficient microwave heating [14, 15]. In this study, we have 
developed a novel resonant-type microwave reactor that is powered by a solid-state 
device. Notably, the frequency of the solid-state oscillator in this system can be tuned to 
efficiently heat a small amount of solution in the resonant cavity, and provide excellent 
heating to the reaction mixture to allow for the synthesis of PET radiopharmaceuticals. 
 
Results and discussion 
Figure 1 shows a picture of the microwave reactor system developed in this 
study, including the resonant cavity and reaction vessel. The key features of this system 
are as follows: (1) a solid-state microwave device, which was originally developed for 
use in cellular phone systems (instead of a magnetron source); (2) a resonant cavity 
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operating in a TM010 single-mode [16]; and (3) a high speed feedback system for tuning 
the frequency and controlling the power. The oscillation unit consists of a voltage 
controlled oscillator (VCO), variable attenuator (VAT), high power amplifier (HPA), 
and programmable logic controller (PLC). Microwave power (50 W max) from the 
oscillation unit was transmitted to the irradiation unit via a coax cable. This newly 
developed microwave reactor can be placed in small spaces such as a hot cell because 




Figure 2 shows the structure of the irradiation unit. The coupling of the 
microwave power to the resonant cavity was made possible by placing an antenna in the 
cavity. The cavity has two openings; one for installing a vial and another for monitoring 
the temperature using an infrared (IR) thermometer. The IR thermometer placed outside 
of the cavity was used to monitor the temperature of the vial. By maintaining the 
resonant conditions at a consistent level, it was possible to reduce the leakage of any 
microwave power from the cavity to a negligible level. Furthermore, this newly 
developed microwave reactor operates in the industrial, scientific and medical 
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frequency band of 2.4–2.5 GHz. It is difficult to calculate the electromagnetic field of a 
region heated with a domestic microwave oven with a multi-mode cavity. In contrast, 
the electromagnetic field of the resonance cavity can be calculated precisely for any 
object placed at the highest energy point in our newly developed microwave reactor. 
This newly developed microwave reactor can therefore provide effective heating whilst 
using minimum electrical power. The dielectric properties of a reaction system can 
change depending on the type of reagents used and the temperature of the system. For 
this reason, the oscillator frequency needs to be repeatedly tuned to the cavity resonance 
during the operation. To address this issue, we equipped our newly developed 
microwave reactor with a feedback control consisting of an electric field and 
frequency-variable solid-state oscillator (2.4–2.5 GHz). In this way, the operator can 
select either a constant microwave power mode or a temperature control mode, where 
the microwave power is automatically adjusted by VAT based on the temperature 
measured by the IR thermometer. The operator can then enter the conditions for their 
synthesis, including the microwave power, irradiation time and temperature of the 
reagent, through a PC interface. Our newly developed microwave reactor was also 
equipped a real-time monitoring system, which allowed for several variables to be 
monitored simultaneously, including (1) the resonance frequency, (2) electric field in the 
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cavity, (3) input power, (4) reflection power, and (5) temperature. The control unit was 
designed to perform various safety functions, such as instigating an automatic shutdown 




Figure 3 shows a simulation of the electrical field distribution in the cavity 
together with a reagent in a borosilicate vial. It is can be seen from the figure that this 
newly developed microwave reactor can effectively irradiate a small amount of solvent 
and provide efficient heating through the direct coupling of microwave energy with the 
molecules that are present in the reaction mixture. This reactor system could therefore 
be used to rapidly and effectively heat a small amount of reaction mixture such as the 




To evaluate the heating efficiency of our new system, we measured the heating 
rate (°C/s) of several high-dielectric loss solvents, including acetonitrile (MeCN), 
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dimethylformamide (DMF), dimethyl sulfoxide (DMSO) and methanol (MeOH). 
Several low-dielectric loss solvents were also investigated, including toluene and 
tetrahydrofuran (THF) (Table 1). The reaction vessel was irradiated with microwave 
irradiation at 50 W (maximum power). The time taken to reach 60 °C, 80 °C and the 
boiling point of each solvent was recorded. Because DMSO has a very high boiling 
point, the third temperature was taken as the maximum temperature of the microwave 
reactor (i.e., 180 °C) instead of the boiling point. 
The experiment revealed that the polar aprotic solvent MeOH possessed the 
fastest heating rate. For DMF and DMSO, which have high boiling points, the 
microwave reactor could efficiently heat these solvents at high temperatures. MeCN, 
which is frequently used as a solvent in PET radiosynthesis, could be heated efficiently 
without a significant decrease in the heating rate, even at its boiling point. It is 
noteworthy that a reduction in the solvent volume (0.05–0.2 mL) had very little impact 
on the rate of heating. It is important to reduce the amount of solvent used in PET 
chemistry, and our newly developed system made it possible to run a reaction using a 
high concentration of precursor. In contrast, toluene and THF, which are both 
low-dielectric loss solvents, had low heating rates. This suggests that the choice of the 






To demonstrate the effectiveness of our newly developed microwave reactor 
through the evaluation of the heating effect, we carried out the radiosynthesis of several 
known PET tracer compounds. 
16α-[18F]Fluoroestradiol ([18F]FES) was selected as a model compound to 
investigate the 18F-fluorination for the sulfonate group [17, 18] (Table 2). [18F]FES is an 
estradiol derivative with the highest bioactivity of all of the known estrogens, and this 
compound be useful for the diagnosis of estrogen-dependent diseases and the evaluation 
of the effectiveness of hormone therapy. Under conventional heating conditions, the 
synthesis of [18F]FES required 10 min of fluorination with [18F]KF in the presence of 
Kryptofix2.2.2 and K2CO3, followed by a 10 min deprotection step with an aqueous 
solution of hydrochloric acid (Table 2, entry 1). When the reaction time was shortened 
under conventional heating conditions, it was not possible to achieve the desired level 
of 18F-fluorination because the 18F-fluorination yield was low and the deprotection 
reaction did not proceed (Table 2, entry 2). In contrast, microwave heating gave a better 
yield of [18F]FES, with each reaction requiring only 1 min (Table 2, entry 3). 
Furthermore, the yield of [18F]FES remained unchanged until the concentration of the 
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amount of the precursor was decreased by 75% (Table 2, entries 4, 5). This indicates 
that it is possible to reduce the amount of precursor used in the synthesis of PET tracers 




The nucleophilic aromatic 18F-fluorination of 
4-[18F]fluoro-N-[2-(1-methoxyphenyl)-1-piperazinyl] ethyl-N-2-pyridinyl-benzamide 
([18F]MPPF), which is used as a PET tracer for the evaluation of the 5-HT1A serotonin 
receptor [19, 20], was also investigated using our newly developed microwave system 
(Table 3). [18F]MPPF was synthesized via the nucleophilic aromatic substitution 
reaction which was facilitated by a neighboring nitro group. Because the 18F anion is 
only weakly nucleophilic, this reaction usually requires a high temperature and a long 
reaction time. The conventional heating of 4-nitro-N-[2-(1-methoxyphenyl)-1- 
piperazinyl]ethyl-N-2-pyridinylbenzamide (nitro-MPPF) in the presence of [18F]KF, 
Kryptofix2.2.2 and K2CO3 at 180 °C for 10 min gave [18F]MPPF in a 26% yield (Table 
3, entry 1), whereas microwave heating gave the product in 74% yield (Table 3, entry 2). 
Raising the temperature of the microwave reaction from room temperature to 180 °C 
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using 50 W of microwave power required 30 sec, and the reaction was maintained at 
this temperature for 1 min. This result showed that microwave heating provides shorter 
reaction times and better yields than conventional heating for 18F-fluorination reactions. 
Furthermore, the use of microwave heating allowed for the formation of the desired 
product in good yield using half of the original concentration of the precursor (Table 3, 
entry 3). Microwave heating gave a better yield than conventional heating until the 
concentration of precursor was decreased by 75% (Table 3, entry 4). In a similar manner 
to the results in Table 2, the results in Table 3showed that the concentration of the 




Finally, we carried out the multistep synthesis of N-succinimidyl 4-[18F] 
fluorobenzoate ([18F]SFB), which has been used for the 18F-labeling of bioactive 
peptides and nucleic acids [21 - 23] (Scheme 1). The synthesis of [18F]SFB requires 
three-steps, including (1) fluorination with [18F]KF in the presence of Kryptofix2.2.2 
and K2CO3; (2) deprotection with tetrapropylammonium hydroxide (TPAH); and (3) 
esterification using N,N,N′,N′-tetramethyl-O-(N-succinimidyl)uranium tetrafluoroborate 
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(TSTU), and these steps require long reaction times We synthesized [18F]SFB under 
microwave heating conditions using our newly developed reactor system. For the 
18F-fluorination, the reaction had preceded by 32% after 1 min under conventional 
heating conditions, whereas microwave heating gave a conversion in excess of 95% 
following the same reaction time. This result demonstrated that microwave irradiation is 
effective for the 18F-fluorination of aromatic compounds such as the SFB precursor. 
Subsequent sequential deprotection and esterification reaction were conducted under 
microwave heating over 1 min each to give the crude product. Finally, purification by 
solid-phase extraction afforded [18F]SFB in a radiochemical yield of 63 ± 4% (decay 
corrected from [18F]KF) with a radiochemical purity of greater than 95% following a 
total synthesis time of 25 ± 5 min. This result therefore provides a clear demonstration 
of the effectiveness of our newly developed microwave reactor for the 18F-fluorination 









We have performed a series of basic examinations of our newly developed 
microwave reactor, which has a resonance-type irradiation mechanism that is different 
from those used in commercially available microwave reactor systems. The microwave 
reactor developed in this study contains a solid-state oscillator, which can be used to 
precisely control the frequency for the generation of the resonant conditions and 
therefore powerfully irradiate a small amount of solvent (0.05–0.5 mL) in the resonant 
cavity. The effectiveness of our newly developed microwave reactor was evaluated in 
terms of the effectiveness of its heating effect by performing the radiosynthesis of three 
completely different PET tracers, including (1) [18F]FES, which was used as a model 
compound to investigate the simple 18F-fluorination for a sulfonate group; (2) 
[18F]MPPF, which was used as a model compound for the nucleophilic aromatic 
substitution of [18F]Fluoride using a nitro group; and (3) [18F]SFB, which was used as a 
model compound for multistep synthesis. Using our newly developed microwave 
reactor, we successfully improved each one of these reactions in terms of their yield and 
the time required for their synthesis compared with the same reactions under 
conventional heating conditions. These results therefore demonstrate that our newly 
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All of the reagents and solvents used in the current study were purchased from 
commercial suppliers and used, as received, without further purification. Dimethyl 
sulfoxide (DMSO), dimethyl formamide (DMF), methanol (MeOH), toluene, 
tetrahydrofuran (THF) and potassium carbonate (K2CO3) were purchased from Wako 
Pure Chemical Industries (Tokyo, Japan). Tetrapropylammonium hydroxide (TPAH) 
and N,N,N′,N′-tetramethyl-O-(N-succinimidyl)uranium tetrafluoroborate (TSTU) were 
purchased from Sigma Aldrich(St. Louis, MO, USA). Kryptofix2.2.2® and anhydrous 
acetonitrile (MeCN) were purchased from Merck (Darmstadt, Germany). The reference 
standard and precursors of FES, MPPF and SFB were purchased from ABX Advanced 
Biochemicals (Radeburg, Germany). Accell Plus CM, Light QMA, Light C18 and Plus 
PS-2 Sep-Pak cartridges were purchased from Waters Corporation (Milford, MA, USA 
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and conditioned with ethanol (10 mL) and sterile water (10 mL) prior to use. The 
reaction vessel was purchased from Oofuna, Ltd. (Osaka, Japan). The material of the 
reaction vessel was borosilicate glass (length: 4.0 cm, diameter: 1.0 cm, maximum 
volume: 3.0 mL). Radio-TLC analysis was performed on silicagel coated aluminium 
plates (60 F254, Merck), which were developed in ethyl acetate–hexane (1:2 v/v) and 
scanned with a sensitive quantitative γ-detecting instrument (miniGITA Star, RAYTEST, 
Straubenhardt, Germany). LC-20AD (Shimadzu Corporation, Kyoto, Japan) was used 
for high-performance liquid chromatography (HPLC) with an SPD-20A (Shimadzu) and 
NDW-351 (Hitachi Aloka Medical, Ltd., Tokyo, Japan) as an ultraviolet detector (ρ: 220 
and 254 nm) and radioisotope detector, respectively. HPLC solvents were of HPLC 
grade. (Nacalai tesque Inc., Kyoto, Japan) 
 
Evaluation of the heating effect on various solvents 
The reaction vessel was charged with solvent (i.e., MeCN, DMF, DMSO, MeOH, 
Toluene or THF), and the solvent was then irradiated using our newly developed 
microwave reactor at 50 W (maximum power).  
 
Example of 18F-fluorination 
[18F]Fluoride was produced by a cyclotron (CYPRIS HM-18, Sumitomo Heavy 
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Industries, Tokyo) via an 18O (p,n) 18F reaction and passed through a Sep-Pak Light 
QMA cartridge (Waters Corporation) as an aqueous solution in 18O-enriched water. The 
cartridge was dried with N2 and the 18F activity was eluted with 1.0 mL of a 
Kryptofix2.2.2/K2CO3 solution [9.5 mg of Kryptofix2.2.2 and 1.7 mg of K2CO3 in 
acetonitrile/water (96/4)]. The solvent was removed by azeotropic dehydration with 
acetonitrile (1.0 mL) at 120 °C under a stream of argon gas at 10 min. 
 
16α-[18F]Fluoroestradiol ([18F]FES) 
To prepare 18F-labeled [18F]FES, a solution of 3-O-methoxymethyl-16,17- 
O-sulfuryl-16-epistriol in acetonitrile (0.1 mL) was added to the reaction vessel 
containing the 18F activity (37–74 MBq). After microwave heating (temperature control 
mode) for 1 min at 100 °C and cooling for 1 min, 0.6 M hydrochloric acid/90% 
acetonitrile (0.1 mL) was added. The mixture was heated for 1 min at 100 °C and cooled 
for 1 min. Total synthesis time was 20 ± 2 min. TLC analysis was carried out with a 
γ-radioactivity TLC scanner (miniGITA Star g-radioactivity TLC scanner, RAYTEST, 






To prepare 18F-labeled 4-[18F]fluoro-N-[2-(1-methoxyphenyl)-1-piperazinyl]ethyl-N-2- 
pyridinylbenzamide ([18F]MPPF), a solution of 4-nitro-N-[2-(1-methoxyphenyl)-1- 
piperazinyl]ethyl-N-2-pyridinylbenzamide (nitro-MPPF) in dimethylsulfoxide (0.1 mL) 
was added to the reaction vessel containing the 18F activity (37–74 MBq). After 
microwave heating (temperature control mode) for 1 min at 180 °C and cooling for 1 
min, Total synthesis time was 17 ± 3 min. TLC analysis was carried out with a 
γ-radioactivity TLC scanner (RAYTEST, decay corrected from [18F]KF). Data are the 
mean ± S.D. (n = 3). 
 
N-succinimidyl 4-[18F] fluorobenzoate ([18F]SFB) 
4-(Ethoxycarbonyl)-N,N,N-trimethylbenzenaminium trifluoromethanesulfonate in 
anhydrous acetonitrile (2.0 mg/0.2 mL) was added to the reaction vessel containing the 
18F activity (3.7–7.4 GBq). After heating for 1 min at 90 °C under microwave irradiation 
(temperature control mode) and cooling for 1 min, the 18F-fluorination was analyzed 
with a γ-radioactivity TLC scanner (RAYTEST). Tetrapropylammonium hydroxide 
(10% in water, 20 µL) was then added to the mixture. The mixture was heated for 1 min 
at 120 °C under microwave irradiation (temperature control mode)  and cooled for 1 
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min, and N,N,N′,N′-tetramethyl-O-(N-succinimidyl)uranium tetrafluoroborate in 
anhydrous acetonitrile (15 mg, 0.2 mL) was then added. After heating for 1 min at 90 °C 
under microwave irradiation (temperature control mode), the mixture was diluted with 
5% acetic acid and applied to a Sep-Pak Accell Plus CM Cartridge (Waters Corporation). 
A Sep-Pak PS-2 Plus Cartridge (Waters Corporation) was attached to the Sep-Pak 
Accell Plus CM Cartridge, and the cartridges were washed with 20 mL of 
acetonitrile/water (20/80). After flowing N2 gas for 10 sec, the Sep-Pak Accell Plus CM 
Cartridge was removed. [18F]SFB was eluted from the Sep-Pak Plus PS-2 Cartridge 
with 2.0 mL of acetonitrile. The isolated radiochemical yield was measured with a 
curiemeter (IGC-7, Hitachi Aloka Medical, Ltd., Tokyo, Japan, decay corrected from 
[18F]KF) and the radiochemical purity of the labeled compounds was determined by 
analytical radio-HPLC. Conditions for HPLC were a Cosmosil 5C-18 AR-II, 4.6 mm × 
150 mm column (Nacalai tesque Inc.); a mobile phase of acetonitrile (A) with 0.1% 
trifluoroacetic acid and water (B) with 0.1% trifluoroacetic acid; 0–8 minutes: 
30%–60% A, 8–15 minutes: isocratic 90% A; and retention time of 4.98 min. Specific 
radioactivity was >14 GBq/µmol calculated by HPLC. Total synthesis time was 25 ± 5 








Figure 1. (a) Resonance-type microwave reactor system (Left: liquid delivering unit, 
Center: resonant cavity, Right: oscillation unit). (b) Resonant cavity (TM010 
single-mode); inner diameter: ø 82 mm, inner height: 30 mm, outer size; depth: 16 cm, 








Figure 2. The structure of the microwave irradiation unit. The vial temperature is 












Figure 3. Simulation of the electromagnetic field in the left half of a borosilicate vessel 























Figure 5. Analytical radio-HPLC chromatogram of crude (a) Ethyl[18F]fluorobenzoate 











Table 1. Evaluation of the heating effect in organic solvents  
*Maximum set temperature of the developed microwave reactor. Data are the mean ± S.D. (n = 3). 
Solvent Time to reach temperature (s) Warming rate (°C/s) 
MeCN   
0.2 mL, 60 °C 8 ± 1 4.3 ± 0.3 
0.2 mL, 80 °C 12 ± 0 4.3 ± 0.1 
0.1 mL, 80 °C 13 ± 1 4.1 ± 0.2 
0.05 mL, 80 °C 12 ± 1 4.2 ± 0.1 
DMF   
0.2 mL, 60 °C 7 ± 1 4.8 ± 0.5 
0.2 mL, 80 °C 10 ± 1 5.6 ± 0.3 
0.2 mL, 150 °C 33 ± 1 3.6 ± 0.1 
DMSO   
0.2 mL, 60 °C 7 ± 1 4.7 ± 0.5 
0.2 mL, 80 °C 11 ± 2 4.9 ± 0.6 
0.2 mL, 180 °C* 35 ± 2 4.3 ± 0.1 
MeOH   
0.2 mL, 65 °C 6 ± 1 5.8 ± 0.4 
Toluene   
0.2 mL, 60 °C 13 ± 1 2.7 ± 0.2 
0.2 mL, 80 °C 18 ± 1 2.9 ± 0.2 
0.2 mL, 110 °C 29 ± 0 2.8 ± 0.1 
THF   
0.2 mL, 65 °C 11 ± 2 3.5 ± 0.3 
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Microwave Yield [%]b 
fluorination deprotection 
1 0.5 mg 100 °C, 10 min 100 °C, 10 min – 68 ± 2 
2 0.5 mg 100 °C, 2 min 100 °C, 2 min – No product 
3 0.5 mg 100 °C, 1 min 100 °C, 1 min + 89 ± 2 
4 0.25 mg 100 °C, 1 min 100 °C, 1 min + 78 ± 7 
5 0.125 mg 100 °C, 1 min 100 °C, 1 min + 70 ± 9 
a [18F]KF: 37 – 74 MBq; MeCN: 0.1 mL; 0.6 M HCl/90% MeCN: 0.1mL  b Determined from 
radio-TLC. Data are the mean ± S.D. (n = 3).  
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Entry Precursor Condition Microwave Yield [%]b 
1 1.500 mg 180 °C, 10 min – 47 ± 10  
2 1.500 mg 180 °C, 1 min + 74 ± 2 
3 0.750 mg 180 °C, 1 min + 56 ± 8  
4 0.375 mg 180 °C, 1 min + 44 ± 3 
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